HCP (HCP) : Traders are bullish on HCP (HCP) as it has outperformed the S&P 500 by a wide margin of 1.08% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.9%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.87% in the last 1 week, and is up 1.47% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
HCP, Inc. is up 23.87% in the last 3-month period. Year-to-Date the stock performance stands at 8.19%. The stock has recorded a 20-day Moving Average of 1.76% and the 50-Day Moving Average is 7.83%.
HCP (NYSE:HCP): The stock opened at $39.72 on Friday but the bulls could not build on the opening and the stock topped out at $39.96 for the day. The stock traded down to $39.26 during the day, due to lack of any buying support eventually closed down at $39.47 with a loss of -0.93% for the day. The stock had closed at $39.84 on the previous day. The total traded volume was 4,020,665 shares.
Also, Raymond James initiates coverage on HCP (NYSE:HCP). The current rating of the shares is Underperform, according to the research report released by the firm. The rating by the firm was issued on July 26, 2016.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.